Jump to content

PubMed RSS Feed - -The many faces of interleukin-17 in inflammatory skin diseases.


Recommended Posts

http:--media.wiley.com-assets-7315-19-Wiley_FullText_120x30_orange.png Related Articles

The many faces of interleukin-17 in inflammatory skin diseases.

Br J Dermatol. 2016 Nov;175(5):892-901

Authors: Speeckaert R, Lambert J, Grine L, Van Gele M, De Schepper S, van Geel N

Interleukin (IL)-17 is an emerging target for inflammatory skin disorders. Given the remarkable success of its therapeutic inhibition in psoriasis, the pathogenic role of this cytokine is being explored in other immune-mediated diseases. Interestingly, IL-17 is linked to particular skin conditions where its activation coincides with disease flares. The leading hypothesis for its contribution to proinflammatory signalling cascades is driving inflammasome activation. However, IL-17 stimulation also releases a range of noninflammasome-related cytokines from human skin. Furthermore, a role in cytotoxic responses and an important interplay with the microbiome is hypothesized. While treatment failure would be surprising in neutrophilic dermatoses, the picture might be more complex in lymphocyte-mediated conditions. Nonetheless, increasing insights into the pathogenesis suggest that beneficial responses are also probable in the latter conditions. Study of this pathway in the skin reveals some intriguing aspects of the IL-17-related immunological network.

PMID: 27117954 [PubMed - indexed for MEDLINE]

{url} = URL to article

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Create New...

Important Information

Terms of Use